Omeros Corporation - Common Stock (NQ:OMER)

18.95 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omeros Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

In today's session, these stocks are experiencing unusual volume. ↗

October 17, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings ↗

October 17, 2025

Via Benzinga

In today's session, these stocks are experiencing unusual volume. ↗

October 16, 2025

Unusual volume stocks are being observed in Thursday's session.

Via Chartmill

Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group

October 16, 2025

From Omeros Corporation

Via Business Wire

Omeros Corp Stock Soars A Whopping 136% Pre-Market After Novo Nordisk Agrees To Buy Its Drug Candidate For Blood Disorder ↗

October 15, 2025

Via Stocktwits

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Earnings Preview: Omeros ↗

August 13, 2025

Via Benzinga

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Examining the Future: Omeros's Earnings Outlook ↗

November 12, 2025

Via Benzinga

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025

November 11, 2025

From Omeros Corporation

Via Business Wire

Breakout Momentum Plays You Need to Know About ↗

October 23, 2025

Three stocks may draw the attention of momentum investors—QURE spiked in September, OMER in October, and SDST has almost 1,000% in upside potential.

Via MarketBeat

4 Biotech Stocks Lifting Off As Momentum Builds ↗

October 21, 2025

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and major indexes reach record levels.

Via Benzinga

Satellogic, Hewlett Packard Enterprise, Bitfarms And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 16, 2025

Via Benzinga

Why J.B. Hunt Transport Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

October 16, 2025

Via Benzinga

A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now? ↗

October 16, 2025

Find out if the deal Omeros announced is enough of a reason to buy this stock.

Via The Motley Fool

Omeros Stock Logs Best Session Ever After HC Wainwright Doubles Target On Novo Nordisk Deal; Retail Sees Big Upside ↗

October 15, 2025

The rally followed H.C. Wainwright’s price target hike to $20 on the back of a $2.1 billion licensing deal with Novo Nordisk for zaltenibart.

Via Stocktwits

Hims & Hers, Salesforce, Omeros, United Airlines, And Sea Ltd: Why These 5 Stocks Are On Investors' Radars Today ↗

October 15, 2025

Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.

Via Benzinga

Topics Stocks

The Terrific Ten Undercard: OMER, VERI, SNYR, MYSE, RDZN – Stocks Under $5 (Complete List Inside)

October 15, 2025

Via AB Newswire

Topics Artificial Intelligence Cannabis

Omeros Stock Skyrockets After Novo Nordisk Strikes $2.1B Rare Disease Drug Deal ↗

October 15, 2025

Omeros stock jumps 164% as Novo Nordisk acquires global rights to zaltenibart, with potential milestones reaching $2.1 billion and tiered royalties.

Via Benzinga

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results ↗

October 15, 2025

Via Benzinga

Omeros Rockets Skyward on $2.1 Billion Novo Nordisk Deal, Reshaping Biotech Landscape

October 15, 2025

In a dramatic turn of events that sent shockwaves through the biotechnology sector, Omeros Corporation (NASDAQ: OMER) witnessed its stock catapult by an astounding nearly 150% after announcing a...

Via MarketMinute

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 15, 2025

Via Benzinga

Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk ↗

October 15, 2025

Novo Nordisk is licensing exclusive global rights to the company's experimental treatment for rare blood and kidney diseases.

Via Investor's Business Daily

Here are the top movers in Wednesday's session. ↗

October 15, 2025

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Via Chartmill

Gapping stocks in Wednesday's session ↗

October 15, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.

Via Chartmill

S&P 500 Gains 1%; Bank of America Posts Upbeat Earnings ↗

October 15, 2025

Via Benzinga

Topics Stocks

Omeros Announces Publication Highlighting Survival Outcomes in TA-TMA Patients Treated with Narsoplimab Under Its Global Expanded Access Program

September 02, 2025

From Omeros Corporation

Via Business Wire

Omeros Posts 2,652 Percent Sales Jump ↗

August 14, 2025

Via The Motley Fool

Omeros Corp (NASDAQ:OMER) Reports Q2 2025: Narrowed Losses, Regulatory Progress, and Market Optimism ↗

August 14, 2025

Omeros Corp (OMER) reports Q2 2025 with narrowed losses, progress on narsoplimab FDA approval, and strategic debt restructuring. Shares rise on regulatory optimism.

Via Chartmill

Omeros Corporation Reports Second Quarter 2025 Financial Results

August 14, 2025

From Omeros Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.